EMA's draft reflection paper promotes using patient experience data in drug regulation to enhance decision-making processes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback